AKTX
Akari Therapeutics
$8.46
−$0.24 (−2.76%)Jul 27, 2026
Key metrics
The numbers that frame AKTX today
- Market cap
- $0.00
- P/E (TTM)
- -0.0
- EV / FCF
- 0.2
- ROIC
- 225.2%
- Div yield
- 0%
- Debt / equity
- 0.1
- 52wk Low
- $3.02
- 52wk High
- $49.60
Growth
Revenue and earnings trend for AKTX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about AKTX
Is Akari Therapeutics a good buy?
No. Akari Therapeutics has poor quality and poor momentum. Both signals point to a weaker setup.
What is the market capitalization of AKTX?
Akari Therapeutics's market capitalization is $0.00.
What is the P/E ratio for AKTX stock?
Akari Therapeutics's current P/E ratio is -0.
What is the 52-week high for AKTX stock?
The 52-week high for Akari Therapeutics is $49.60. The current close of $8.46 is 82.9% below that high.
What is the 52-week low for AKTX stock?
The 52-week low for Akari Therapeutics is $3.02. The current close of $8.46 is 180.6% above that low.
Does AKTX stock pay dividends?
Akari Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for AKTX?
Akari Therapeutics's Debt / Equity ratio is 0.05.